Bioactivity:

WNK-IN-B is an inhibitor of Wnk signalling. WNK-IN-B is a cell-permeable diaminoacridine derivative that targets the CCT domain of SPAK and OSR1 via reversible binding. WNK-IN-B selectively suppress hypotonic shock-induced WNK signaling pathway activation

CAS nr:

332922-63-1

Purity:

98%

Molecular Weight:

333,39

SMILES:

NC1=C(C=CC(NCC2=CC=CO2)=C3)C3=NC4=CC=C(OCC)C=C41

Formula:

C20H19N3O2

Pathway:

Target: